[Federal Register Volume 70, Number 38 (Monday, February 28, 2005)]
[Notices]
[Pages 9681-9682]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-3734]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
April 20 and 21, 2005. A sample of agenda items to be discussed during 
the public sessions includes: (1) Status of Rulemaking: Pt. 35 Training 
and Experience; (2) Status and Update: Redefining Medical Events; (3) 
Case Experience in Using I-125 Seeds as Markers; (4) FDA Radiation Dose 
Limits for Human Research Subjects Using Certain Radiolabeled Drugs, 
and (5) Establishing Guidance on Exceeding Dose Limits for Members of 
the Public who would serve as Caregivers to Persons undergoing 
Radiopharmaceutical Therapy. To review the agenda, see http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda/ or contact 
[email protected]. Furthermore, the ACMUI will brief the Commission regarding 
its activities, on April 20, 2005.
    Purpose: Discuss issues related to 10 CFR 35, Medical Use of 
Byproduct Material.
    Dates and Times for Public Meetings: April 20, 2005, from 8 a.m. to 
5 p.m.; and April 21, 2005, from 10 a.m. to 5 p.m.
    Address for Public Meetings: Bethesda North Marriott Hotel & 
Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. The 
precise room number where the meeting will be held will be announced in 
reader boards located throughout the hotel.
    Date and Time for Closed Session Meeting: April 21, 2005, from 8 
a.m. to 10 a.m. This session will be closed so that NRC staff can brief 
the ACMUI on sensitive information regarding protective security 
measures, and so that the ACMUI can discuss internal personnel matters.
    Address for Closed Session Meeting: Bethesda North Marriott Hotel & 
Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. The 
precise room number where the meeting will be held will be announced in 
reader boards located throughout the hotel.
    Date and Time for Commission Briefing: April 20, 2005, from 9:30 
a.m. to 11:30 a.m.
    Address for Commission Briefing: U.S. Nuclear Regulatory 
Commission, One White Flint North Building, Commissioners' Hearing Room 
1G16, 11555 Rockville Pike, Rockville, MD, 20852-2738.

FOR FURTHER INFORMATION CONTACT: Angela R. McIntosh, telephone (301) 
415-5030; e-mail [email protected] of the Office of Nuclear Material Safety 
and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the

[[Page 9682]]

meeting in a manner that will facilitate the orderly conduct of 
business. The following procedures apply to public participation in the 
meeting:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Angela R. McIntosh, U.S. Nuclear Regulatory 
Commission, Two White Flint North, Mail Stop T8F5, 11545 Rockville 
Pike, Rockville, MD 20852-2738. Submittals must be postmarked by April 
1, 2005, and must pertain to the topics on the agenda for the meeting.
    2. Questions from members of the public will be permitted during 
the meeting, at the discretion of the Chairman.
    3. The transcript and written comments will be available for 
inspection on NRC's Web site (http://www.nrc.gov) and at the NRC Public 
Document Room, 11555 Rockville Pike, Rockville, MD 20852-2738, 
telephone (800) 397-4209, on or about July 20, 2005. This meeting will 
be held in accordance with the Atomic Energy Act of 1954, as amended 
(primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. 
App); and the Commission's regulations in Title 10, U.S. Code of 
Federal Regulations, part 7.
    4. Attendees are requested to notify Angela R. McIntosh at (301) 
415-5030 of their planned attendance if special services, such as for 
the hearing impaired, are necessary.

    Dated at Rockville, Maryland, this 22nd day of February, 2005.

    For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 05-3734 Filed 2-25-05; 8:45 am]
BILLING CODE 7590-01-P